Gb Sciences Stock Book Value Per Share
GBLX Stock | USD 0.01 0 36.00% |
GB Sciences fundamentals help investors to digest information that contributes to GB Sciences' financial success or failures. It also enables traders to predict the movement of GBLX Pink Sheet. The fundamental analysis module provides a way to measure GB Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GB Sciences pink sheet.
GBLX |
GB Sciences Company Book Value Per Share Analysis
GB Sciences' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current GB Sciences Book Value Per Share | (0) X |
Most of GB Sciences' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GB Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Competition |
In accordance with the recently published financial statements, the book value per share of GB Sciences is about -0.004 times. This is 99.76% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The book value per share for all United States stocks is 100.0% higher than that of the company.
GBLX Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GB Sciences' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GB Sciences could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics of similar companies.GB Sciences is currently under evaluation in book value per share category among related companies.
GBLX Fundamentals
Return On Equity | -50.98 | |||
Return On Asset | -0.21 | |||
Current Valuation | 10.19 M | |||
Shares Outstanding | 379.21 M | |||
Shares Owned By Insiders | 13.08 % | |||
Price To Earning | 4.04 X | |||
Price To Book | 1.08 X | |||
Price To Sales | 1.91 X | |||
Gross Profit | (881.46 K) | |||
EBITDA | 398.73 K | |||
Net Income | (530.87 K) | |||
Cash And Equivalents | 53.96 K | |||
Total Debt | 397.31 K | |||
Debt To Equity | 1.07 % | |||
Current Ratio | 0.03 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (1.87 M) | |||
Beta | 0.56 | |||
Market Capitalization | 8.21 M | |||
Total Asset | 2.55 M | |||
Retained Earnings | (78.28 M) | |||
Working Capital | 881 K | |||
Current Asset | 2.2 M | |||
Current Liabilities | 1.32 M | |||
Z Score | -30.0 | |||
Net Asset | 2.55 M |
About GB Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GB Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GB Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GB Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GB Sciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GB Sciences' short interest history, or implied volatility extrapolated from GB Sciences options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GB Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for GBLX Pink Sheet analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |